Uri Aharon - RedHill Biopharma Insider

RDHL -- USA Stock  

USD 7.90  0.06  0.77%

Chief Accounting Officer

Mr. Uri Hananel Aharon serves as Chief Accounting Officer at Redhill Biopharma Ltd, effective since 2012. His work experience includes the following roles Team Manager at Ernst Young Israel and Accounting Intern at Ziv Haft, BDO . He holds a Bachelors degree in Accounting and Economics from The Hebrew University of Jerusalem and a MBA degree, majoring in Business Taxation, from the College of Management Academic Studies, Rishon LeZion.
Age: 35  Executive Since 2011  MBA    
972 3 541 3131  http://www.redhillbio.com
Aharon is a graduate of the Hebrew University and the Academic College for Management, Rishon Lezion .

Management Efficiency

The company has return on total asset (ROA) of (48.58) % which means that it has lost $48.58 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (84.52) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on the development and commercialization of late clinical-stage, proprietary, and in-licensedacquired drugs for the treatment of gastrointestinal and inflammatory diseases, and cancer. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 74 people.RedHill Biopharma Ltd (RDHL) is traded on Nasdaq Capital Markets in USA. It is located in ISRAEL and employs 74 people. RedHill Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.

RedHill Biopharma Leadership Team

Patricia Anderson, President
Micha Chorin, CFO
Ofer Tsimchi, Director
Patrick Mclean, Executive
Aida Bibliowicz, President, MBA
Ori Shilo, CEO, MBA
Shmuel Cabilly, Director
Dror BenAsher, Chairman
Kenneth Reed, Director, Ph.D
Elkan Gamzu, Executive, Ph.D
Adi Frish, SVP
Guy Goldberg, Executive
Reza Fathi, SVP, Ph.D
Tom Lang, President
Clara Fehrmann, Executive
Pascal Weerts, Director
Eric Swenden, Director
Dan Suesskind, Director
Gilead Raday, President
Rick Scruggs, Director
Terry Plasse, Director
Danielle Abramson, Director
Uri Aharon, Executive, MBA
Shani Maurice, President
Patricia Bandeira, Executive, MBA
Ira Kalfus, Director, Ph.D
Nurit Benjamini, Director, MBA

Stock Performance Indicators

Did you try this?

Run Premium Stories Now
   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Premium Stories

Trending Equities

Currently Active Assets on Macroaxis
MSE   
Purchased over 300 shares of
few hours ago
Traded for 34.4
VUSA   
Purchased over 500 shares of
few hours ago
Traded for 1895.0
C   
Purchased over 40 shares of
few hours ago
Traded for 67.2
V   
Purchased over 20 shares of
few hours ago
Traded for 135.33
MDR   
Purchased over 100 shares of
few hours ago
Traded for 20.94
Additionally take a look at Your Equity Center. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.